Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie Van Bebber

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Current Opinion in Molecular Therapeutics|June 7, 2008
Challenges to the translation of genomic information into clinical practice and health policy: Utilization, preferences and economic valueKathryn A Phillips, Su-Ying Liang, Stephanie Van Bebber, et al.
Nature Reviews. Drug Discovery|May 24, 2006
Diagnostics and biomarker development: priming the pipelineKathryn A Phillips, Stephanie Van Bebber, Amalia M Issa
Pharmacogenomics|April 30, 2003
An introduction to cost-effectiveness and cost-benefit analysis of pharmacogenomicsKathryn A Phillips, David Veenstra, Stephanie Van Bebber, et al.
Preventing Chronic Disease|June 17, 2006
A review of studies examining stated preferences for cancer screeningKathryn A Phillips, Stephanie Van Bebber, Deborah Marshall, et al.
Neurology|June 19, 2015
Patients optimizing epilepsy management via an online community: the POEM StudyJohn D Hixson, Deborah Barnes, Karen Parko, et al.
Managed Care Interface|April 9, 2005
A qualitative study of insurers' coverage for mifepristone-induced abortionMarcel P Gemperli, Felicia H Stewart, Kathryn A Phillips, et al.
Health Economics|February 5, 2009
How do physician assessments of patient preferences for colorectal cancer screening tests differ from actual preferences? A comparison in Canada and the United States using a stated-choice surveyDeborah A Marshall, F Reed Johnson, Nathalie A Kulin, et al.
Current Drug Safety|August 12, 2008
Drug withdrawals in the United States: a systematic review of the evidence and analysis of trendsAmalia M Issa, Kathryn A Phillips, Stephanie Van Bebber, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Current Opinion in Molecular Therapeutics|June 7, 2008
Challenges to the translation of genomic information into clinical practice and health policy: Utilization, preferences and economic valueKathryn A Phillips, Su-Ying Liang, Stephanie Van Bebber, et al.
Nature Reviews. Drug Discovery|May 24, 2006
Diagnostics and biomarker development: priming the pipelineKathryn A Phillips, Stephanie Van Bebber, Amalia M Issa
Pharmacogenomics|April 30, 2003
An introduction to cost-effectiveness and cost-benefit analysis of pharmacogenomicsKathryn A Phillips, David Veenstra, Stephanie Van Bebber, et al.
Preventing Chronic Disease|June 17, 2006
A review of studies examining stated preferences for cancer screeningKathryn A Phillips, Stephanie Van Bebber, Deborah Marshall, et al.
Neurology|June 19, 2015
Patients optimizing epilepsy management via an online community: the POEM StudyJohn D Hixson, Deborah Barnes, Karen Parko, et al.
Managed Care Interface|April 9, 2005
A qualitative study of insurers' coverage for mifepristone-induced abortionMarcel P Gemperli, Felicia H Stewart, Kathryn A Phillips, et al.
Health Economics|February 5, 2009
How do physician assessments of patient preferences for colorectal cancer screening tests differ from actual preferences? A comparison in Canada and the United States using a stated-choice surveyDeborah A Marshall, F Reed Johnson, Nathalie A Kulin, et al.
Current Drug Safety|August 12, 2008
Drug withdrawals in the United States: a systematic review of the evidence and analysis of trendsAmalia M Issa, Kathryn A Phillips, Stephanie Van Bebber, et al.
Pageof 1